A Study in Healthy Adult Volunteers to Assess the Safety and Pharmacokinetics of an Investigational Imaging Product
PHASE1CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
October 25, 2018
Primary Completion Date
May 20, 2019
Study Completion Date
May 20, 2019
Conditions
Healthy Subjects
Interventions
DRUG
ASP5354
Intravenous
DRUG
Placebo
Intravenous
Trial Locations (1)
32117
Covance CRU, Daytona Beach, Daytona Beach
All Listed Sponsors
lead
Astellas Pharma Global Development, Inc.
INDUSTRY
NCT03698305 - A Study in Healthy Adult Volunteers to Assess the Safety and Pharmacokinetics of an Investigational Imaging Product | Biotech Hunter | Biotech Hunter